Skip to content

Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-527164-32-00
Enrollment
36
Registered
2026-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy participants

Interventions

None listed

Sponsors

Laboratorios Alter S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Jul 18, 2026